Learn how to connect pre, during, and post-congress engagement into a unified omnichannel strategy
Wednesday, December 17th, 2025
3:30 PM CET / 9:30 AM ET
Head of Omnichannel Engagement International
CEO
The countdown has started
When it comes to congress participation, pharma teams focus on three key areas: establishing a strong booth presence, generating engagement, and measuring impact and ROI. Let’s face it, mastering this is already a significant achievement, but many teams still miss out on using congresses as a strategic omnichannel engagement tool with timely and meaningful follow-up. After all, this is where the true impact and ROI are realized.
In this 30-minute episode, Sander Ruitenberg, Head of Omnichannel Engagement International at CSL, joins Onomi CEO Pierre Metrailler to discuss what it looks like when a company genuinely adopts an omnichannel approach. Sander will explain how to transform congresses into omnichannel campaigns rather than isolated events, and why treating them as campaigns leads to clearer ownership, better results, and greater customer impact.
They will discuss how to start engaging healthcare professionals (HCPs) well before the booth opens, how a global CRM layer can connect onsite interactions back to local markets, and how to use adoption and knowledge ladders to customize booth experiences in real time. You will hear practical examples of what is working today, where the gaps are, and how to turn casual conversations in coffee lines and booth visits into structured insights that help accelerate customer journeys instead of ending at the booth.
This session is for commercial excellence, omnichannel, medical affairs, and congress leaders who want to connect congress engagement with real customer impact. It is especially relevant for teams struggling with disconnected systems, inconsistent data capture, or congress plans that never translates into meaningful follow-up.
Onomi is the event-powered omnichannel solution that helps life science companies to create personalized, engaging, and compliant experiences for Healthcare Professionals. From omnichannel webinars and advisory boards to in-person congresses and standalone meetings, Onomi covers a wide range of medical event use cases, while enabling successful omnichannel strategies through deep CRM integrations including Veeva CRM, Veeva Vault CRM, IQVIA OCE, and Salesforce.
With 22+ years of unrivaled experience in the event technology industry, Onomi is the first choice for HCP engagement. Onomi technology is trusted by 15 of the top 20 life science companies.
For more information about how Onomi can help you increase HCP engagement and gather valuable data to drive effective follow-up, reach out today.
Head of Omnichannel Engagement International
CSL
With more than 20 years of experience in the pharma industry and a master’s degree in medicine, he is a passionate and driven leader in digital health. He has launched and led digital campaigns, programs, and products across multiple disease areas and markets, delivering innovative customer experiences that can be easily customized and localized.
His expertise spans user experience design, product development, digital governance, and omnichannel marketing. He has also worked on connected care programs and digital health partnerships, supporting organizational transformation and digital excellence. His mission is to harness data and digital capabilities to create transformative, personalized experiences for patients, healthcare professionals, and stakeholders across the healthcare ecosystem.
CEO
Pierre is an event technology pioneer with over 20 years of experience. After joining SpotMe in 2001, he expanded the company’s vision from hardware-based networking devices to comprehensive event engagement solutions. He led the company’s transformation to a SaaS platform in 2011, with a strong focus on enterprise customers. As CEO since 2016, Pierre has pursued a CRM-first strategy and addressed critical industries’ unmet needs, launching Onomi, an event-powered omnichannel solution for life sciences. He holds degrees from the Swiss Federal Institute of Technology, Lausanne and INSEAD.
